SPG’s expertise in state and federal policy analysis, strategic planning, and health equity impact assessments. The addition of SPG enables Ankura to provide tailored solutions that address the complex challenges clients face amid shifting public policies, technological advances, and competitive market dynamics.

Jeffrey A. Sachs, CEO of SPG, shared his excitement about becoming part of Ankura, emphasizing, “SPG’s focus on helping healthcare clients navigate changes in public policy, technology, and the global marketplace aligns seamlessly with Ankura’s mission to provide expert advisory and solutions for clients in moments of change and disruption. We will leverage this powerful synergy to provide clients with the tools and strategies they need to thrive in an ever-evolving landscape.” Ankura’s CEO, Kevin Lavin, emphasized that the acquisition strengthens the firm’s advisory and execution capabilities in healthcare and life sciences. He welcomed the SPG team and highlighted their value in helping clients manage risks, seize opportunities, and drive innovation with confidence. Together, Ankura and SPG aim to deliver enhanced insights and strategies for clients navigating the healthcare landscape.

Read more